DAXglobal Sarasin Sustainability Germany EUR
|
2 975,30
|
0,78
|
0,03 %
|
Analysen zu DAXglobal Sarasin Sustainability Germany EUR-Werten
| 01.02.24 | Merck Overweight | JP Morgan Chase & Co. | |
| 01.02.24 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | SAP Add | Baader Bank | |
| 01.02.24 | BMW Buy | Deutsche Bank AG | |
| 01.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 01.02.24 | ABB Neutral | UBS AG | |
| 01.02.24 | adidas Hold | Warburg Research | |
| 01.02.24 | adidas Buy | Deutsche Bank AG | |
| 01.02.24 | adidas Hold | Jefferies & Company Inc. | |
| 01.02.24 | adidas Overweight | JP Morgan Chase & Co. | |
| 01.02.24 | adidas Reduce | Baader Bank | |
| 31.01.24 | adidas Sector Perform | RBC Capital Markets | |
| 31.01.24 | adidas Buy | UBS AG | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | K+S Halten | DZ BANK | |
| 31.01.24 | Allianz Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | KRONES Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 31.01.24 | K+S Hold | Warburg Research | |
| 31.01.24 | Fresenius Overweight | Barclays Capital | |
| 31.01.24 | Fresenius Medical Care Equal Weight | Barclays Capital | |
| 31.01.24 | Fresenius Buy | Warburg Research | |
| 31.01.24 | Continental Neutral | UBS AG | |
| 31.01.24 | Carl Zeiss Meditec Underperform | Bernstein Research | |
| 31.01.24 | Deutsche Börse Buy | Warburg Research | |
| 31.01.24 | MorphoSys Hold | Deutsche Bank AG | |
| 31.01.24 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
| 31.01.24 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.01.24 | Roche Neutral | UBS AG | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 30.01.24 | WACKER CHEMIE Verkaufen | DZ BANK | |
| 30.01.24 | Roche Sell | Deutsche Bank AG | |
| 30.01.24 | Fraport Sell | Deutsche Bank AG | |
| 30.01.24 | K+S Hold | Jefferies & Company Inc. | |
| 30.01.24 | Carl Zeiss Meditec Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 30.01.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | Brenntag Buy | UBS AG | |
| 30.01.24 | MorphoSys Buy | UBS AG | |
| 30.01.24 | Bilfinger Buy | Deutsche Bank AG |